Morgan Stanley Maintains Equal-Weight on Accolade, Lowers Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Equal-Weight rating on Accolade (NASDAQ:ACCD) and lowers the price target from $13 to $12.
April 26, 2024 | 4:33 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley maintains an Equal-Weight rating on Accolade and lowers the price target from $13 to $12.
The reduction in price target by Morgan Stanley suggests a tempered outlook on Accolade's stock performance in the short term, potentially leading to negative investor sentiment and a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100